News Releases

Explore all the latest news from Johnson & Johnson Vision around the globe.*

Acuvue
Johnson & Johnson Vision Receives Approval of World’s First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen
The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved the first combination contact lens that provides vision correction and an antihistamine drug to help relieve symptoms for…
Johnson & Johnson Vision Receives Approval of World’s First and Only Drug-Releasing Combination Contact Lens for Vision Correction and Allergic Eye Itch: ACUVUE® Theravision™ with Ketotifen
Johnson & Johnson Vision Introduces New ACUVUE® OASYS MULTIFOCAL with PUPIL OPTIMIZED DESIGN and Expands the ACUVUE® OASYS Portfolio of Offerings for Patients with Presbyopia
Johnson & Johnson Vision Introduces New ACUVUE® OASYS MULTIFOCAL with PUPIL OPTIMIZED DESIGN and Expands the ACUVUE® OASYS Portfolio of Offerings for Patients with Presbyopia
Newest member of the ACUVUE® OASYS Brand Family designed to deliver crisp, clear reliable vision at all distances, regardless of age or refractive error.  The new lens is designed for…
Johnson & Johnson Vision Introduces New ACUVUE® OASYS MULTIFOCAL with PUPIL OPTIMIZED DESIGN and Expands the ACUVUE® OASYS Portfolio of Offerings for Patients with Presbyopia
Johnson & Johnson Vision announces CE mark for new ACUVUE® OASYS MULTIFOCAL contact lens
Johnson & Johnson Vision announces CE mark for new ACUVUE® OASYS MULTIFOCAL contact lens

ACUVUE® OASYS MULTIFOCAL with PUPIL OPTIMIZED™ DESIGN is the newest member of the ACUVUE® OASYS brand family for patients with presbyopia, set to launch across Europe in…

Johnson & Johnson Vision announces CE mark for new ACUVUE® OASYS MULTIFOCAL contact lens

Feature Stories

Johnson & Johnson Media Center

For more information about the latest Johnson & Johnson
news and publications visit the Media Center at www.jnj.com

Johnson & Johnson Media Center

Social Media LIVE

 

*Johnson & Johnson Vision medical device information contained in the News Releases are specific to the market highlighted and is not intended for dissemination outside the intended market.

PP2023OTH5448